IRIS Accounts Production v23.3.1.45 12497314 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true false Ordinary 0.0100 Ordinary A 0.0100 Ordinary B 0.0100 Ordinary C 0.0100 Ordinary D 0.0100 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh124973142022-12-31124973142023-12-31124973142023-01-012023-12-31124973142021-12-31124973142022-01-012022-12-31124973142022-12-3112497314ns14:PoundSterlingns10:Original2023-01-012023-12-3112497314ns10:Originalns10:Director12023-01-012023-12-3112497314ns10:Original2023-01-012023-12-3112497314ns10:Original2023-12-3112497314ns10:Originalns10:PrivateLimitedCompanyLtd2023-01-012023-12-3112497314ns10:Originalns10:SmallEntities2023-01-012023-12-3112497314ns10:Originalns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3112497314ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3112497314ns10:SmallCompaniesRegimeForAccountsns10:Original2023-01-012023-12-3112497314ns10:Originalns10:FullAccounts2023-01-012023-12-3112497314ns10:Original12023-01-012023-12-3112497314ns10:Originalns10:OrdinaryShareClass12023-01-012023-12-3112497314ns10:Originalns10:OrdinaryShareClass22023-01-012023-12-3112497314ns10:OrdinaryShareClass3ns10:Original2023-01-012023-12-3112497314ns10:Originalns10:OrdinaryShareClass42023-01-012023-12-3112497314ns10:Originalns10:OrdinaryShareClass52023-01-012023-12-3112497314ns10:Original2022-12-3112497314ns10:Originalns5:CurrentFinancialInstruments2023-12-3112497314ns10:Originalns5:CurrentFinancialInstruments2022-12-3112497314ns10:Originalns5:Non-currentFinancialInstruments2023-12-3112497314ns10:Originalns5:Non-currentFinancialInstruments2022-12-3112497314ns5:ShareCapitalns10:Original2023-12-3112497314ns5:ShareCapitalns10:Original2022-12-3112497314ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-12-3112497314ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3112497314ns10:Originalns10:RegisteredOffice2023-01-012023-12-3112497314ns5:IntangibleAssetsOtherThanGoodwillns10:Original2023-01-012023-12-3112497314ns10:Originalns5:ComputerEquipment2023-01-012023-12-3112497314ns10:Original2022-01-012022-12-3112497314ns10:Originalns5:PatentsTrademarksLicencesConcessionsSimilar2023-01-012023-12-3112497314ns10:Originalns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-3112497314ns10:Originalns5:ComputerEquipment2023-12-3112497314ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3112497314ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3112497314ns10:Originalns5:CurrentFinancialInstruments2023-01-012023-12-3112497314ns10:Originalns5:Non-currentFinancialInstruments2023-01-012023-12-3112497314ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-12-3112497314ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-12-3112497314ns10:Originalns10:OrdinaryShareClass12023-12-3112497314ns10:Originalns10:OrdinaryShareClass22023-12-3112497314ns10:OrdinaryShareClass3ns10:Original2023-12-3112497314ns10:Originalns10:OrdinaryShareClass42023-12-3112497314ns10:Originalns10:OrdinaryShareClass52023-12-31
REGISTERED NUMBER: 12497314 (United Kingdom)















Unaudited Financial Statements for the Year Ended 31 December 2023

for

INJECTACLAD LTD

INJECTACLAD LTD (REGISTERED NUMBER: 12497314)

Contents of the Financial Statements
for the Year Ended 31 December 2023










Page

Balance Sheet 1

Notes to the Financial Statements 3


INJECTACLAD LTD (REGISTERED NUMBER: 12497314)

Balance Sheet
31 December 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1 -
Tangible assets 5 605 -
606 -

CURRENT ASSETS
Stocks 6 51,772 -
Debtors 7 78,439 51,490
Cash at bank 275,337 80,608
405,548 132,098
CREDITORS
Amounts falling due within one year 8 280,413 123,816
NET CURRENT ASSETS 125,135 8,282
TOTAL ASSETS LESS CURRENT LIABILITIES 125,741 8,282

CREDITORS
Amounts falling due after more than one
year

9

(66,081

)

-

PROVISIONS FOR LIABILITIES (151 ) -
NET ASSETS 59,509 8,282

CAPITAL AND RESERVES
Called up share capital 11 101 101
Retained earnings 59,408 8,181
SHAREHOLDERS' FUNDS 59,509 8,282

INJECTACLAD LTD (REGISTERED NUMBER: 12497314)

Balance Sheet - continued
31 December 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 March 2024 and were signed on its behalf by:





Mr R Lewis - Director


INJECTACLAD LTD (REGISTERED NUMBER: 12497314)

Notes to the Financial Statements
for the Year Ended 31 December 2023


1. STATUTORY INFORMATION

Injectaclad Ltd is a private company, limited by shares , registered in United Kingdom. The company's registered number and registered office address are as below:

Registered number: 12497314

Registered office: Unit 7 Llandough Trading Estate
Penarth Road
Cardiff
CF11 8RR

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses..

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% Straight line

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


INJECTACLAD LTD (REGISTERED NUMBER: 12497314)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of
business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing
borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of
transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss
Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer
settlement of the liability for at least twelve months after the reporting date.

INJECTACLAD LTD (REGISTERED NUMBER: 12497314)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023


2. ACCOUNTING POLICIES - continued

Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is
deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends
Dividend distribution to the company's shareholders is recognised as a liability in the financial statements in
the reporting period in which the dividends are declared.

Financial instruments
Classification
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Debt instruments are subsequently measured at amortised cost.

Impairment
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2022 - 4 ) .

4. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
Additions 1
At 31 December 2023 1
NET BOOK VALUE
At 31 December 2023 1


INJECTACLAD LTD (REGISTERED NUMBER: 12497314)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023


5. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
Additions 807
At 31 December 2023 807
DEPRECIATION
Charge for year 202
At 31 December 2023 202
NET BOOK VALUE
At 31 December 2023 605

6. STOCKS
2023 2022
£    £   
Stocks 51,772 -

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 75,867 51,389
Other debtors 101 101
Prepayments 2,471 -
78,439 51,490

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts (see note 10) 9,950 -
Trade creditors 79,805 59,006
Social security and other taxes 73,212 18,526
Other creditors 109,887 -
Accruals and deferred income 7,559 46,284
280,413 123,816

The loans and borrowings are secured by fixed and floating charge over the assets of the company

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£    £   
Bank loans (see note 10) 66,081 -

INJECTACLAD LTD (REGISTERED NUMBER: 12497314)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023


9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued

The loans and borrowings are secured by fixed and floating charge over the assets of the company.

10. LOANS

An analysis of the maturity of loans is given below:

2023 2022
£    £   
Amounts falling due within one year or on demand:
Bank loans 9,950 -

Amounts falling due between two and five years:
Bank loans - 2-5 years 66,081 -

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
25,252 Ordinary £0.00 1 25 25
22,916 Ordinary A £0.00 1 23 23
22,916 Ordinary B £0.00 1 23 23
5,000 Ordinary C £0.00 1 5 5
1,000 Ordinary D £0.00 1 1 1
1,000 Ordinary E £0.00 1 1 1
22,916 Ordinary F £0.00 1 23 23
101 101